SAMRAT PHARMACHEM
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Samrat Pharmachem along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.87₹ -2.15
As on Dec 17, 2025, 2:19 PM IST
Samrat Pharmachem Price Performance
Today's LowToday's High
₹244.50₹254.40
₹246.25
52 Weeks' Low52 Weeks' High
₹237.00₹449.45
₹246.25
Open Price
₹254.40
Prev. Close
₹248.40
Volume
454
Over the last 5 years, the share price of Samrat Pharmachem has gained 13.11% CAGR. Over the past year, the corresponding return has been -41.93%.
Samrat Pharmachem’s current P/E of 48.48x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Samrat Pharmachem Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Samrat Pharmachem | -0.1 | -8.13 | -24.61 | -28.02 | -41.93 | -31.97 | 13.11 |
| Sun Pharmaceutical Industries | 0.32 | 1.6 | 10.6 | 8.68 | 0.14 | 21.98 | 25.7 |
| Divi's Laboratories | -0.11 | -3.64 | 3.88 | -3.85 | 7.46 | 23.44 | 10.48 |
| Torrent Pharmaceuticals | -1.18 | -1.8 | 5.77 | 15.25 | 10.89 | 32.91 | 22.14 |
| Cipla | 0.26 | -2.82 | -4.25 | -0.7 | 2.93 | 10.9 | 13.81 |
| Dr. Reddy's Laboratories | 1.65 | 2.19 | -2.99 | -3.58 | 1.9 | 13.08 | 4.61 |
| Lupin | 2.69 | 2.86 | 3.9 | 8.59 | 3.15 | 42.55 | 16.81 |
| Zydus Lifesciences | -0.73 | -1.85 | -11.39 | -4.37 | -5.42 | 30.9 | 14.08 |
| Mankind Pharma | -1.95 | -6.2 | -18.02 | -10.49 | -20.87 | 13.91 | 8.13 |
| Aurobindo Pharma | 1.57 | -3.83 | 8.53 | 7.24 | -1.95 | 39.66 | 6.46 |
| Alkem Laboratories | 0.18 | -2.01 | 2.42 | 16.53 | 4.07 | 23.17 | 13.82 |
| Abbott India | -0.97 | -6.24 | -10.31 | -12.72 | -0.9 | 9.96 | 11.5 |
| Glenmark Pharmaceuticals | -0.27 | 4.4 | -4.62 | 17.77 | 28.76 | 67.26 | 30.36 |
| Laurus Labs | -0.97 | -1.36 | 12.85 | 52.64 | 76.49 | 37.54 | 24.15 |
| Biocon | 1.91 | -8.33 | 8.97 | 9.54 | 10.08 | 13.73 | -3.44 |
| GlaxoSmithKline Pharmaceuticals | -0.3 | 3.71 | -5.55 | -20.56 | 14.08 | 24.73 | 10.26 |
| Anthem Biosciences | 3.49 | 0.19 | -22.79 | -8.71 | -8.71 | -2.99 | -1.8 |
| Ipca Laboratories | -4.99 | -4.91 | 6.05 | 2.52 | -10.7 | 17.64 | 5.16 |
| Ajanta Pharma | -2.12 | 3.83 | 1.46 | 2.06 | -9.53 | 30.21 | 18.71 |
| J B Chemicals & Pharmaceuticals | -1.66 | -2.25 | 5.13 | 3.2 | -2.55 | 20.06 | 26.99 |
Over the last one year, Samrat Pharmachem has declined 41.93% compared to peers like Sun Pharmaceutical Industries (0.14%), Divi's Laboratories (7.46%), Torrent Pharmaceuticals (10.89%). From a 5 year perspective, Samrat Pharmachem has underperformed peers relative to Sun Pharmaceutical Industries (25.70%) and Divi's Laboratories (10.48%).
Samrat Pharmachem Financials
Samrat Pharmachem Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 249.84 | 251.22 |
| 10 | 252.2 | 252.56 |
| 20 | 258.92 | 257.67 |
| 50 | 279.08 | 274.54 |
| 100 | 304.1 | 295.91 |
| 200 | 329.32 | 323.46 |
Samrat Pharmachem Share Holding Pattern
In the latest quarter, Samrat Pharmachem remained same as its previous close in promoter holding, while DII stake decreased to 0.00%, FII holding rose to 3.24%, and public shareholding unchanged at 47.67% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Samrat Pharmachem Corporate Actions
Date Time | Announcement |
|---|---|
| Dec 02, 2025, 8:58 PM IST | Samrat Pharma - Announcement under Regulation 30 (LODR)-Credit Rating |
| Nov 15, 2025, 2:15 AM IST | Samrat Pharma - Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2025 |
| Nov 15, 2025, 2:06 AM IST | Samrat Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held Today |
| Oct 10, 2025, 8:27 PM IST | Samrat Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 27, 2025, 7:11 PM IST | Samrat Pharma - Corporate Action-Board approves Dividend |
About Samrat Pharmachem
Samrat Pharmachem Ltd. is a Public Limited Listed company incorporated on 16/06/1992 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1992PLC017820 and registration number is 017820. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 285.86 Cr. and Equity Capital is Rs. 3.09 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No A2/3445, Ankleshwar Gujarat 393002
- Contact
Management
- Mr. Lalit MehtaChairman & Managing Director
- Mr. Rajesh MehtaExecutive Director & CFO
- Mr. Megh MehtaExecutive Director
- Ms. Renu DharodInd. Non-Executive Director
- Mr. Manishkumar PipaliaInd. Non-Executive Director
- Mr. Sachin KotharyInd. Non-Executive Director
- Ms. Megha JainInd. Non-Executive Director
FAQs on Samrat Pharmachem Share Price
What is the share price of Samrat Pharmachem?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Samrat Pharmachem is ₹246.25 as on Dec 17, 2025.
What kind of stock is Samrat Pharmachem?
The Samrat Pharmachem is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Samrat Pharmachem?
The market cap of Samrat Pharmachem is ₹76.08 Cr as on Dec 17, 2025.
What are today's High and Low prices of Samrat Pharmachem?
Today’s highest and lowest price of Samrat Pharmachem are ₹254.40 and ₹244.50.
What are the 52 Week High and 52 Week Low of Samrat Pharmachem?
The 52-week high/low is the highest and lowest price at which Samrat Pharmachem stock has traded in the past 52-week or nearly a year. The 52-week high of Samrat Pharmachem is ₹449.45 and 52-week low of Samrat Pharmachem is ₹237.00 as on Dec 17, 2025.
How has the Samrat Pharmachem performed historically in terms of returns?
The Samrat Pharmachem has shown returns of -0.87% over the past day, -8.13% for the past month, -24.61% over 3 months, -41.93% over 1 year, -31.97% across 3 years, and 13.11% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Samrat Pharmachem?
P/E ratio of and PB ratio of Samrat Pharmachem are 48.48 and 1.06 on Dec 17, 2025. While the company gives a dividend yield of 0.41 per annum.
✕
Market Pulse